Edition:
United Kingdom

CanniMed Therapeutics Inc (CMED.TO)

CMED.TO on Toronto Stock Exchange

35.67CAD
23 Feb 2018
Change (% chg)

$0.23 (+0.65%)
Prev Close
$35.44
Open
$35.86
Day's High
$35.90
Day's Low
$35.13
Volume
173,283
Avg. Vol
375,711
52-wk High
$46.00
52-wk Low
$7.32

Select another date:

Tue, Feb 6 2018

BRIEF-Aurora Cannabis And Cannimed Therapeutics File Offer Documents For Previously Announced Friendly Acquisition

* AURORA CANNABIS AND CANNIMED THERAPEUTICS FILE OFFER DOCUMENTS FOR PREVIOUSLY ANNOUNCED FRIENDLY ACQUISITION Source text for Eikon: Further company coverage:

UPDATE 4-Canada's Aurora Cannabis to buy rival to create world's most valuable weed firm

Jan 24 Canada's No. 2 marijuana producer Aurora Cannabis Inc has agreed to buy smaller rival CanniMed Therapeutics Inc for C$1.1 billion ($852 million) as companies jostle to benefit from the country's legalization of recreational marijuana use later this year.

FACTBOX-World's biggest marijuana M&A, stake purchase deals

Jan 24 Canada's second-biggest marijuana producer Aurora Cannabis Inc has agreed to buy smaller rival CanniMed Therapeutics Inc for C$1.1 billion ($852 million), creating the world's largest weed producer by market value. The agreement topped global cannabis merger and acquisition activity, pushing deal values so far in 2018 to far above those in entire previous years. It brought the total value of marijuana-related mergers and acquisitions to $1.2 billion so far in 2018, mo

BRIEF-Aurora Cannabis, Cannimed Therapeutics Agree To Terms On Friendly Transaction

* AURORA CANNABIS AND CANNIMED THERAPEUTICS AGREE TO TERMS ON FRIENDLY TRANSACTION

Cannabis producer Aurora to buy CanniMed for C$1.1 bln

Jan 24 Canadian marijuana producer Aurora Cannabis on Wednesday agreed to buy CanniMed Therapeutics Inc for about C$1.1 billion ($892.21 million), gearing up to meet an expected surge in demand at home and globally.

BRIEF-CanniMed Therapeutics Announces Continued Discussions With Aurora

* CANNIMED THERAPEUTICS ANNOUNCES CONTINUED DISCUSSIONS WITH AURORA

Canadian cannabis firm Aurora in talks to buy both CanniMed and Newstrike: sources

TORONTO Canadian marijuana producer Aurora Cannabis Inc is in talks with rivals CanniMed Therapeutics Inc and Newstrike Resources Ltd to buy both businesses in a friendly deal that would create the nation's top weed company, people familiar with the matter told Reuters on Friday.

UPDATE 1-Canadian cannabis firm Aurora in talks to buy both CanniMed and Newstrike -sources

TORONTO, Jan 19 Canadian marijuana producer Aurora Cannabis Inc is in talks with rivals CanniMed Therapeutics Inc and Newstrike Resources Ltd to buy both businesses in a friendly deal that would create the nation's top weed company, people familiar with the matter told Reuters on Friday.

Canadian cannabis firm Aurora in talks to buy both CanniMed and Newstrike -sources

TORONTO, Jan 19 Canadian marijuana producer Aurora Cannabis Inc is in talks with rivals CanniMed Therapeutics Inc and Newstrike Resources Ltd to acquire both companies in a friendly deal, people familiar with the situation told Reuters on Friday.

Canadian cannabis firm CanniMed in talks with suitor Aurora

TORONTO Canadian cannabis producer CanniMed Therapeutics Inc said it has postponed a shareholder vote on its proposed takeover of Newstrike Resources Ltd to allow it to discuss a possible transaction with hostile suitor Aurora Cannabis Inc .

Select another date: